No-Cost, No-Obligation Zantac Cancer Attorney Case Review

Antacid Cancer Attorney
Zantac Lawsuit News

Sanofi May Attempt To Put Online Testing Pharmacy On Trial And Force Them To Defend Their Handling of Ranitidine

It is hard to tell which side has the advantage going into the Zantac cancer litigation scientific discovery phase

Thursday, November 4, 2021 - Zantac cancer plaintiffs now numbering in the thousands have completed the questionnaire asking about their experience with heartburn and acid reflux medicine and their cancer diagnosis. Those that qualify make up a plaintiff pool where each has a common injury from having taken Zantac ranitidine regularly for many years. Each plaintiff claims to have developed a type of cancer like stomach, bladder, esophagus, colon, and prostate cancer. Zantac cancer lawsuits have been filed from every state in America by plaintiffs alleging a similar type of heartburn medicine cancer. All cases are consolidated into a single group called multidistrict litigation (MDL) where administrative court proceedings and scientific discovery are performed once instead of thousands of times. Multidistrict litigation is preferred in cases that involve complex scientific testimony like this one. Experts expect that more than one hundred thousand cases may eventually qualify to file against Sanofi, the maker of Zantac, and expect the Zantac cancer litigation to be the largest mass tort legal action in history, exceeding that of asbestos and tobacco. More than 15 million Americans were using Zantac when it was first discovered by online prescription drug testing pharmacy Valisure to contain high levels of NDMA.

Science day for thousands of Zantac cancer lawsuits organized into multidistrict litigation is scheduled for December 2, just about a month from now. During the proceedings, expert witness testimony from the defense and plaintiffs will try and pursuance a Judge Rosenberg that their work best explains why ranitidine turns into N-nitrosodimethylamine, a well-known deadly carcinogen. The Zantac multidistrict litigation is in the state of Florida because there are so many Zantac cancer plaintiffs living there. U.S. District Judge Robin Rosenberg in West Palm Beach is in the process of selecting 450 plaintiffs that have taken Zantac and now have one of ten specific types of cancer. Several cases will be selected from that narrowed-down pool of 450 to serve as bellwether trials that may begin as early as July of 2023, according to Reuters. Each prospective plaintiff must have been able to prove that they took Zantac ranitidine regularly for more than a year and that they have been diagnosed with cancer. Most qualifying cancers are those of the stomach and gastrointestinal system and also breast cancer. One recent lawsuit was filed by a man with pancreatic cancer.

Sanofi's defense of the safety of ranitidine may lie in their lawyer's ability to convince jurors that the ranitidine molecule must be super-heated to very high temperatures to produce a toxic level of NDMA, which is exactly what Valisure may have done. Valisure is on record of having modified the FDA tests and increased the heat that may be responsible for the NDMA spike. The defense will also highlight the FDA's ranitidine recall which was made out of an abundance of caution, not because of elevated levels of the carcinogen. The FDA's tests of ranitidine in the wake of the Valisure allegations found levels of NDMA only slightly above the 96 nanograms per tablet threshold the FDA set, a level they admit may have been overly cautious, to begin with. The 96 nanogram threshold was based on a user taking the recommended dosage of ranitidine continuously for many years, and it was the cumulative effect of NDMA that was dangerous to health.

More Recent Heartburn MedicineLawsuit News:

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.

Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.